Kevin P. Starr

Director, Alnylam Pharmaceuticals.

Companies

Sage Therapeutics, Inc.Board member Jul 17, 2014 to Jun 16, 2023¹
Alnylam PharmaceuticalsBoard member Jun 2, 2006 to Jun 6, 2017²
Zafgen (United States)Board member Jun 18, 2014 to Sep 25, 2015³
Global Blood Therapeutics, Inc.Board member Aug 11, 2015 to Aug 19, 2015⁴
Agios PharmaceuticalsBoard member Jul 23, 2013 to Feb 19, 2015⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Recent filings

Nov 10, 2021Other 1,000,000 shares of Fulcrum Therapeutics (United States)⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSage Therapeutics, Inc., Board member
2
SEC EDGARAlnylam Pharmaceuticals, Board member
3
SEC EDGARZafgen (United States), Board member
4
SEC EDGARGlobal Blood Therapeutics, Inc., Board member
5
SEC EDGARAgios Pharmaceuticals, Board member
6
SEC EDGARForm 4 filed Nov 12, 2021